Global Transcatheter Mitral Valve Replacement (TMVR) Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application

TMVR, also known as transcatheter mitral valve replacement is a way of replacing the mitral valve in the heart without the need for conventional open-heart surgery. TMVR transcatheter mitral valve replacement is a treatment for mitral valve stenosis (tight mitral valve) or mitral valve regurgitation (leaky mitral valve) or a mix of the two. TMVR transcatheter mitral valve replacement was developed initially as a method of replacing the mitral valve in patients considered too high risk for surgery but will likely replace mitral valve replacement surgery in the future as the technology improves and the outcomes are proved.
The classification of Transcatheter Mitral Valve Replacement (TMVR) includes MitraClip, Edwards PASCAL and Edwards SAPIEN 3. The market share of MitraClip in 2019 reached up to over 96%.
United States and Europe are the largest consumption place, with a revenue market share nearly 96% in 2019. The rest of global market mostly was taken up by China and Japan, which totally occupied a market share of over 2%.

Market Analysis and Insights: Global Transcatheter Mitral Valve Replacement (TMVR) Market
The research report studies the Transcatheter Mitral Valve Replacement (TMVR) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Transcatheter Mitral Valve Replacement (TMVR) market size is projected to reach US$ 5019.5 million by 2027, from US$ 906.4 million in 2020, at a CAGR of 27.7% during 2021-2027.

Global Transcatheter Mitral Valve Replacement (TMVR) Scope and Segment
The global Transcatheter Mitral Valve Replacement (TMVR) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transcatheter Mitral Valve Replacement (TMVR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
MitraClip
Edwards PASCAL
Edwards SAPIEN 3

Segment by Application
Functional Mitral Regurgitation (FMR)
Degenerative Mitral Regurgitation (DMR)

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Micro Interventional Devices
Neovasc
LivaNova
HighLife SAS